Trial NCT03819660

View at ClinicalTrials.gov 
Org. Study IDs: SMA-002

Last trial update was posted on 2023-11-30

MeSH Interventions

Amifampridine

MeSH Conditions

Atrophy Muscular Atrophy Muscular Atrophy, Spinal

Other Conditions

Spinal Muscular Atrophy Type 3

Stopping Reasons

Development of indication not being pursued

Limitations And Caveats

The results of efficacy are limited to the assessment of quality of life using the INQoL. The premature interruption of the study determined that few patients had available data of INQoL from Month 6 onwards.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID